These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26308787)

  • 1. Hyperuricemia and gout in solid-organ transplant: update in pharmacological management.
    Sullivan PM; William A; Tichy EM
    Prog Transplant; 2015 Sep; 25(3):263-70. PubMed ID: 26308787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gout in solid organ transplantation: a challenging clinical problem.
    Stamp L; Searle M; O'Donnell J; Chapman P
    Drugs; 2005; 65(18):2593-611. PubMed ID: 16392875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
    Fujimori S
    Nihon Rinsho; 2008 Apr; 66(4):729-35. PubMed ID: 18409523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermal tophus: a complication of gout in a kidney transplant recipient.
    Ayvazoglu Soy EH; Karakaya E; Karatas Togral A; Akdur A; Moray G; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():276-9. PubMed ID: 25894172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating gout in kidney transplant recipients.
    Baroletti S; Bencivenga GA; Gabardi S
    Prog Transplant; 2004 Jun; 14(2):143-7. PubMed ID: 15264458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing new-onset gout in pediatric renal transplant recipients: when, how, to what extent.
    Assadi F
    J Nephrol; 2013; 26(4):624-8. PubMed ID: 22941874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperuricemia and gout following pediatric renal transplantation.
    Spartà G; Kemper MJ; Neuhaus TJ
    Pediatr Nephrol; 2006 Dec; 21(12):1884-8. PubMed ID: 16947031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Febuxostat for the chronic management of hyperuricemia in patients with gout.
    Chinchilla SP; Urionaguena I; Perez-Ruiz F
    Expert Rev Clin Pharmacol; 2016; 9(5):665-73. PubMed ID: 26942273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperuricemia and gout: new insights into pathogenesis and treatment.
    Pillinger MH; Rosenthal P; Abeles AM
    Bull NYU Hosp Jt Dis; 2007; 65(3):215-21. PubMed ID: 17922673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts.
    Bakris GL; Doghramji PP; Keenan RT; Silber SH
    Am J Med; 2014 Jan; 127(1):S1. PubMed ID: 24268074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout.
    Ernst ME; Fravel MA
    Clin Ther; 2009 Nov; 31(11):2503-18. PubMed ID: 20109996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gout management: an update].
    Ankli B; Krähenbühl S
    Ther Umsch; 2016; 73(3):115-24. PubMed ID: 27008442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uric acid and transplantation.
    Mazzali M
    Semin Nephrol; 2005 Jan; 25(1):50-5. PubMed ID: 15660335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prophylaxis on gout flares after the initiation of urate-lowering therapy: analysis of data from three phase III trials.
    Wortmann RL; Macdonald PA; Hunt B; Jackson RL
    Clin Ther; 2010 Dec; 32(14):2386-97. PubMed ID: 21353107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase for the treatment of hyperuricemia in kidney transplant recipients.
    Tojimbara T; Nakajima I; Yashima J; Fuchinoue S; Teraoka S
    Transplant Proc; 2014; 46(2):511-3. PubMed ID: 24656001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis for acute gout flares after initiation of urate-lowering therapy.
    Latourte A; Bardin T; Richette P
    Rheumatology (Oxford); 2014 Nov; 53(11):1920-6. PubMed ID: 24758886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing your patient with gout: a review of treatment options.
    Doghramji PP
    Postgrad Med; 2011 May; 123(3):56-71. PubMed ID: 21566416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of gout: a 57-year-old man with a history of podagra, hyperuricemia, and mild renal insufficiency.
    Shmerling RH
    JAMA; 2012 Nov; 308(20):2133-41. PubMed ID: 23188030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case 9: initiation of urate-lowering therapy for advanced gout complicated by chronic renal insufficiency.
    Edwards NL
    Am J Med; 2006 Nov; 119(11 Suppl 1):S29-31. PubMed ID: 17059911
    [No Abstract]   [Full Text] [Related]  

  • 20. Gout: joints and beyond, epidemiology, clinical features, treatment and co-morbidities.
    Robinson PC; Horsburgh S
    Maturitas; 2014 Aug; 78(4):245-51. PubMed ID: 24880206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.